Tuesday, August 18, 2026

Metabia Begins Dosing First Patient in Phase 1 Part 3 Trial of Obesity Drug DA-1726

Metabia begins Phase 1 trial for DA-1726, a dual-action obesity treatment, aiming for safety and efficacy in weight loss by 2026.

Trump Extends Iran Negotiation Deadline: What Does It Mean for WTI Oil Prices?

Trump's extension of Iran negotiation deadline causes a 1% drop in WTI crude oil futures, despite earlier gains in prices.

Is Your AI Assistant Causing Brain Overload? Discover the Hidden Costs of Overusing AI Tools

AI agents, once seen as productivity enhancers, now overwhelm users, causing mental fatigue and decision fatigue in the workplace.

Tag: boycott

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.